OS Therapies Inc (OSTX) Form 8-K — Sep 9, 2026

$OSTXForm 8-KItems 5.02, 5.07, 9.01Filed Sep 9, 2026, 4:17 PM ET0001213900-26-098403Original filing

OS Therapies Incorporated (NYSE American: OSTX) reported that its 2026 annual meeting of stockholders, held September 9, 2026, re-elected all six director nominees: Paul A. Romness, John Ciccio, Craig Eagle, Avril McKean Dieser, Olivier R. Jarry and Theodore F. Search.

Key figures

Shares Outstanding: 46205601
Plan Approval For: 4515930
Directors Elected: 6
Plan Share Reserve: 15000000
Plan Broker Non Votes: 18655392
Plan Approval Abstain: 2002913
Plan Approval Against: 885667
Auditor Ratification For: 25689179
Shares Present At Meeting: 26059902
Auditor Ratification Abstain: 30079
Auditor Ratification Against: 340644
Plan Share Reserve Pct Of Shares Outstanding: ~32.5% (computed: 15,000,000 / 46,205,601)

Price after filing

1 day: -2.2%7 days: -5.9%30 days: -12.9%

Close on the filing date to close N calendar days later (from $1.86). Historical, not a forecast.

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.